We are live on ! Find out more

Butterfly Network

BFLY

Market cap $2.01B

7.51 USD

-0.30

3.84%

At close Updated Oct 29, 4:00 PM EDT

Pre-market

After hours

7.28

-0.23

3.06%

1 day

-3.84%

5 days

9.64%

1 month

-17.47%

3 months

5.77%

6 months

52.64%

Year to date

100.27%

1 year

249.3%

5 years

-27.23%

10 years

-24.14%

About: Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. The company operates in one reportable segment, which includes all activities related to the development, manufacture, and sale of the Company's products, software, and other services.

Employees: 220

Healthcare Medical Devices

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 20.7%

Neutral 72.4%

Negative 6.9%

Butterfly Network Q3 Earnings Call Highlights

Butterfly Network NYSE: BFLY reported third-quarter 2026 revenue of $32.6 million, up 52% from a year earlier and 9% above the high end of its guidance range, as growth in its Embedded business and enterprise-focused point-of-care ultrasound operations lifted results.

Butterfly Network Q3 Earnings Call Highlights

Butterfly Network, Inc. (BFLY) Q3 2026 Earnings Call Transcript

Butterfly Network, Inc. ( BFLY ) Q3 2026 Earnings Call October 29, 2026 8:00 AM EDT Company Participants John Doherty - Executive VP & CFO Joseph DeVivo - CEO, President & Chairman of the Board Conference Call Participants Joshua Jennings - TD Cowen, Research Division William Plovanic - Canaccord Genuity Corp., Research Division David Saxon - Needham & Company, LLC, Research Division Daniel Markowitz - Evercore ISI Institutional Equities, Research Division Steven Lichtman - William Blair & Company L.L.C., Research Division Benjamin Haynor - Lake Street Capital Markets, LLC, Research Division Ilya Zubkov - Freedom Broker, Research Division Presentation Operator Hello, everyone.

Butterfly Network, Inc. (BFLY) Q3 2026 Earnings Call Transcript

Zacks Investment Research

Butterfly Network, Inc. (BFLY) Reports Q3 Loss, Beats Revenue Estimates

Butterfly Network, Inc. (BFLY) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.13 per share a year ago.

Butterfly Network, Inc. (BFLY) Reports Q3 Loss, Beats Revenue Estimates

Butterfly Network Reports Third Quarter 2026 Financial Results

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly” or the “Company”), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced financial results for the third quarter ended September 30, 2026, and provided a business update. Joseph DeVivo, Butterfly's President, Chief Executive Officer and Chairman commented, “Our third quarter results came in ahead of guidance on both revenue and adjusted E.

Butterfly Network Reports Third Quarter 2026 Financial Results

Butterfly Network to Present at UBS Global Healthcare Conference on November 10, 2026

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a pioneer and leader in semiconductor-based ultrasound devices, cloud software and AI, today announced that it will attend the UBS Global Healthcare Conference in Palm Beach Garden, FL on November 10, 2026. Joseph DeVivo, President, Chief Executive Officer & Chairman and John Doherty, EVP, Chief Financial Officer, will present and host one-on-one investor meetings. The company presentation wil.

Butterfly Network to Present at UBS Global Healthcare Conference on November 10, 2026

The Edward Via College of Osteopathic Medicine (VCOM) and Butterfly Network Announce Long-Term Alliance to Build New Model for Ultrasound Education

BURLINGTON, Mass. & BLACKSBURG, Va.--(BUSINESS WIRE)---- $BFLY #POCUS--The Edward Via College of Osteopathic Medicine (VCOM) and Butterfly Network, Inc. (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound devices, cloud software and AI, today announced a long-term alliance and joint investment in establishing VCOM and its students as a center of excellence for ultrasound education and community care. The first-of-its-kind program combines one-probe-per-student deployment, integrated education a.

The Edward Via College of Osteopathic Medicine (VCOM) and Butterfly Network Announce Long-Term Alliance to Build New Model for Ultrasound Education

Beyond Elon Musk's Neuralink: Two Public Stocks With a Stake in the Brain Race

Elon Musk's Neuralink is giving us a glimpse of a future in which the human brain can communicate directly with computers. For investors, there's just one problem: You can't buy Neuralink stock.

Beyond Elon Musk's Neuralink: Two Public Stocks With a Stake in the Brain Race

Butterfly Network to Report Third Quarter 2026 Financial Results on October 29, 2026

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, announced that it will report third quarter 2026 financial results on Thursday, October 29, 2026, at 8:00 am ET. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and John Doherty, Executive Vice President and Chief Financial Officer, will host a conference call and webcas.

Butterfly Network to Report Third Quarter 2026 Financial Results on October 29, 2026

Butterfly Network Lands Multi-Year Bridge Neurotech Deal

Butterfly Network Inc. (NYSE:BFLY) is partnering with Bridge Neurotech to develop a fully non-invasive brain-computer interface using ultrasound technology.

Butterfly Network Lands Multi-Year Bridge Neurotech Deal

Bridge Neurotech and Butterfly Network Announce Partnership to Develop Fully Non-Invasive Brain-Computer Interface

BURLINGTON, Mass. & REDWOOD CITY, Calif.--(BUSINESS WIRE)---- $BFLY #BCI--Bridge Neurotech ("Bridge"), which emerged from stealth today with the goal of building a completely non-invasive brain-computer interface (BCI), and Butterfly Network, Inc. ("Butterfly") (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound, programmable cloud software and AI, today announced a research and development agreement through Butterfly Embedded™. Bridge was founded with a mission to make BCIs possible without.

Bridge Neurotech and Butterfly Network Announce Partnership to Develop Fully Non-Invasive Brain-Computer Interface

See News Rankings

Price charts implemented using Lightweight Charts™